RAPAMYCINRapamycin Price

Rapamycin, also known by its chemical name sirolimus, is a macrolide compound that was first discovered in the early 1970s, specifically in 1972, from Streptomyces hygroscopicus, a bacterium found in the soil of Rapa Nui (Easter Island). Initially developed as an immunosuppressive drug, rapamycin is employed in clinical settings to prevent organ transplant rejection. However, recent research has expanded its relevance beyond immunosuppression, uncovering a fascinating ability to promote longevity across various biological species, including worms, fruit flies, and mice.

The primary mechanism through which rapamycin exerts its effects is by inhibiting the mechanistic target of rapamycin (mTOR) pathway. mTOR is a pivotal regulator of cell growth, metabolism, and proliferation. By targeting this pathway, rapamycin induces a state of cellular rejuvenation, leading to improved health outcomes and longevity.